Ventyx Biosciences, Inc.VTYXNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
15.41%
↑ 170% above average
Average (22q)
-22.06%
Historical baseline
Range
High:58.67%
Low:-231.56%
Volatility
-1315.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 15.41% |
| Q2 2025 | 1.65% |
| Q1 2025 | 6.51% |
| Q4 2024 | 16.73% |
| Q3 2024 | -10.33% |
| Q2 2024 | 17.17% |
| Q1 2024 | 17.50% |
| Q4 2023 | 13.46% |
| Q3 2023 | -1.46% |
| Q2 2023 | -36.78% |
| Q1 2023 | -10.56% |
| Q4 2022 | -15.60% |
| Q3 2022 | -52.17% |
| Q2 2022 | 11.94% |
| Q1 2022 | -27.94% |
| Q4 2021 | -39.10% |
| Q3 2021 | 17.90% |
| Q2 2021 | 58.67% |
| Q1 2021 | -125.39% |
| Q4 2020 | -133.43% |
| Q3 2020 | -231.56% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |